Evidence map›Paper›PMID 32159613›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2020

Kidney health for everyone everywhere - from prevention to detection and equitable access to care.

P Kam-Tao Li, G Garcia-Garcia, Siu-Fai Lui, S Andreoli, W Wing-Shing Fung, A Hradsky, L Kumaraswami, V Liakopoulos, Z Rakhimova, G Saadi and 4 more

Open access · goldAbstract readEditorial
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Chronic kidney diseases: A realm for preventive nephrology.Journal of family medicine and primary care · 2020
    Review
  15. Article
  16. Renoprotective Effects ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 7 countries.

P Kam-Tao LiDepartment of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong.ORCID http://orcid.org/0000-0001-9879-8388
G Garcia-GarciaNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Guadalajara, Mexico.ORCID http://orcid.org/0000-0003-0558-0035
Siu-Fai LuiDivision of Health System, Policy and Management, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong.ORCID http://orcid.org/0000-0003-0800-8982
S AndreoliJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
W Wing-Shing FungDepartment of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong.ORCID http://orcid.org/0000-0001-7676-7628
A HradskyWorld Kidney Day Office, Brussels, Belgium.
L KumaraswamiTanker Foundation, Chennai, India.
V LiakopoulosDivision of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-7564-2724
Z RakhimovaWorld Kidney Day Office, Brussels, Belgium.
G SaadiNephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt.ORCID http://orcid.org/0000-0002-6280-1685
L StraniWorld Kidney Day Office, Brussels, Belgium.
I UlasiRenal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria.ORCID http://orcid.org/0000-0001-7783-3025
K Kalantar-ZadehDivision of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Orange, CA, USA.ORCID http://orcid.org/0000-0002-8666-0725
World Kidney Day 2020 Steering Committee
Chinese University of Hong Kong · HKAristotle University of Thessaloniki · GRCairo University · EGRiley Hospital for Children · USUniversidad de Guadalajara · MXUniversity of California, Irvine · USUniversity of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. However, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions - be it primary, secondary, or tertiary. This article focuses on outlining and analyzing measures that can be implemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management, and treatment are often lacking. Hence, there is an urgent need to increase the awareness of preventive measures throughout populations, professionals, and policy makers.

Indexed as

Global Burden of DiseaseHealth EquityHealth Services AccessibilityEarly DiagnosisHealth PolicyHealth PromotionHumansMass ScreeningPreventive Health ServicesRenal Insufficiency, ChronicRisk Factors

Identifiers

PMID32159613
PMCPMC7076785
OpenAlexW3012268226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.